Abstract
Following the imposition of a hemodynamic load, the primary adaptive response of the heart involves an increase in size of individual cardiac myocytes in the absence of cell division. This process is characterized as cardiac hypertrophy and the pattern of individual myocyte growth is directly influenced by the nature of the hemodynamic load. Cardiac hypertrophy can be classified as either physiological or pathological and their disparate phenotypes are related in part to a divergent pattern of peptide growth factor expression. Gq-mediated recruitment of Ca2+- and PKC-dependent signaling pathways may primarily be implicated in the progression of pathological hypertrophy characterized by a concentric pattern of remodeling. By contrast, recruitment of the phosphatidylinositol 3-kinase isoform p110α may selectively participate in the physiological growth of cardiac myocytes. However, there exists evidence to suggest that Ca2+-dependent pathways may also play a supporting role in physiological cardiac hypertrophy. Thus, this review will provide a comprehensive analysis of the morphological, cellular, and molecular phenotypes of physiological and pathological cardiac hypertrophy and explore the relative contribution of Gq- and phosphatidylinositol 3-kinase-dependent pathways.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Adams, J.W., Sakata, Y., Davis, M.G., Sah, V., Wang, Y., Ligget, S.B., Chein, K.R., Brown, J.H., and Dorn, G.W., II. 1998. Enhanced Gαq signalling: A common pathway mediates cardiac hypertrophy and apoptotic heart failure. Proc. Natl. Acad. Sci. USA 95:10140-10145.
Anversa, P., Levicky, V., Beghi, C., McDonald, S.L., and Kikkawa, Y. 1983. Morphometry of exercise-induced right ventricular hypertrophy in the rat. Circ. Res. 52:57-64.
Anversa, P., Ricci, R., and Olivetti, G. 1986. Quantitative structural analysis of the myocardium during physiological growth and induced cardiac hypertrophy: a review. J. Am. Coll. Cardiol. 7:1140-1149.
Black, F.M., Packer, S.E., Parker, T.G., Michael, L.H., Roberts, R., Schwartz, R.J., and Schneider, M.D. 1991. The vascular smooth muscle α-actin gene is reactivated during cardiac hypertrophy provoked by load. J. Clin. Invest. 79:970-977.
Braunwald, E. 1992. Heart Disease: A Textbook of Cardiovascular Medicine (4th ed.). Saunders, Philadelphia.
Braz, J., Gregory, K., Pathak, A., Zhao, W., Sahin, B., Klevitsky, R., Kimball, T.F., Lorenz, J.N., Nairn, A.C., Liggett, S.B., Bodi, I., Wang, S., Schwartz, A., Lakatta, E.G., DePaoli-Roach, A.A., Robbins, J., Hewett, T.E., Bibb, J.A., Westfall, M.V., Kranias, E.G., and Molkentin, J.D. 2004. PKC-alpha regulates cardiac contractility and propensity toward heart failure. Nature Med. 10:248-254.
Calderone, A., Takahashi, N., Izzo, N.J., Thaik, C.M., and Colucci, W.S. 1995. Pressure- and volume-induced left ventricular hypertrophies are associated with distinct myocyte phenotypes and differential induction of peptide growth factor mRNAs. Circulation 92:2385-2390.
Calderone, A., Takahashi, N., Thaik, C., and Colucci, W.S. 1998. Atrial natriuretic peptide, nitric oxide and cGMP inhibit the growth-promoting effects of norepinephrine in cardiac myocytes and fibroblasts. J. Clin. Invest. 101:812-818.
Calderone, A., Abdelaziz, N., Colombo, F., Schreiber, K.L., and Rindt, H. 2000. A farnesyltrans-ferase inhibitor attenuates cardiac myocyte hypertrophy and gene expression. J. Mol. Cell. Car-diol. 32:1127-1140.
Calderone, A., Murphy, R.J.L., Lavoie, J., Colombo, F., and Beliveau, L. 2001. TGF-β1 and prepro-ANP mRNAs are differentially regulated in exercise-induced cardiac hypertrophy. J. Appl. Physiol. 91:771-776.
Colomer, J.M., and Means, A.R. 2000. Chronic elevation of calmodulin in the ventricles of trans-genic mice increases the autonomous activity of calmodulin-dependent protein kinase II, which regulates atrial natriuretic factor gene expression. Mol. Endocrinol. 14:1125-1136.
Crackower, M.A., Oudit, G.Y., Kozieradzki, I., Sarao, R., Sun, H., Sasaki, T., Irie-Sasaki, J., Sah, R., Cheng, H.-Y.M., Rybin, V.O., Lembo, G., Fratta, L., Oliveira-dos-Santos, A.J., Benovic, J.L., Kahn, C.R., Izumo, S., Steinberg, S.F., Wymann, M.P., Backx, P.H., and Penninger, J.P. 2002. Regulation of myocardial contractility and cell size by distinct PI3K-PTEN signalling pathways. Cell 110:737-749.
de la Bastie, D., Levitsky, D., Rappaport, L., Mercadier, J.J., Marotte, F., Wisnewsky, C., Brovkovich, V., Schwartz, K., and Lompre, A.M. 1990. Function of the sarcoplasmic reticu-lum and expression of its Ca2+ ATPase gene in pressure overload-induced cardiac hypertrophy in the rat. Circ. Res. 66:554-565.
Delaughter, M.C., Taffet, G.E., Fiorotto, M.L., Entman, M.L., and Schwartz, R.L. 1999. Local insulin-like growth factor expression induces physiologic, then pathologic, cardiac hypertrophy in transgenic mice. FASEB J. 13:1923-1929.
Diffee, G.M., Seversen, E.A., Stein, T.D., and Johnson, J.A. 2003. Microarray expression analy-sis of effects of exercise training: increase in atrial MLC-1 in rat ventricles. Am. J. Physiol. 284:H830-H837.
Ellmers, L.J., Knowles, J.W., Kim, H.S., Smithies, O., Maeda, N., and Cameron, V.A. 2002. Ven-tricular expression of natriuretic peptides in Npr1(-/-) mice with cardiac hypertrophy and fibro-sis. Am. J. Physiol. 283:H707-H714.
Eto, Y., Yonekura, K., Sonoda, M., Arai, N., Sata, M., Sugiura, S., Takenaka, K., Gualberto, A., Hixon, M.L., Wagner, M.W., and Aoyagi, T. 2000. Calcineurin is activated in rat hearts with physiological left ventricular hypertrophy induced by voluntary exercise training. Circulation 101:2134-2137.
Geenen, D.L., Malhotra, A., and Buttrick, P.M. 1996. Angiotensin receptor 1 blockade does not prevent physiological cardiac hypertrophy in the adult rat. Am. J. Physiol. 81:816-821.
Gerdes, A.M., Campbell, S.E., and Hilbelink, D.R. 1988. Structural remodelling of cardiac my-ocytes in rats with arteriovenous fistula. Lab. Invest. 59:857-861.
Grossman, W., Jones, D., and McLaurin, L.P. 1975. Wall stress and patterns of hypertrophy in the human left ventricle. J. Clin. Invest. 56:56-64.
Hainsey, T., Csiszar, A., Sun, S., and Edwards, J.G. 2002. Cyclosporin A does not block exercise-induced cardiac hypertrophy. Med Sci. Sports. Exerc. 34:1249-1254.
Huang, C.-H., Hao, L.-Y., and Buetow, D.E. 2002. Insulin-like growth factor-induced hypertrophy of cultured adult rat cardiomyocytes is L-type calcium-channel-dependent. Mol. Cell. Biochem. 231:51-59.
Iemitsu, M., Miyauchi, T., Maeda, S., Sakai, S., Kobayashi, T., Fujii, N., Miyazaki, H., Matsuda, M., and Yamaguchi, I. 2001. Physiological and pathological cardiac hypertrophy induce different molecular phenotypes in the rat. Am. J. Physiol. 281:R2029-R2036.
Ito, H., Hiroe, M., Hirata, Y., Fujisaki, H., Adachi, S., Akimoto, H., Ohta, Y., and Marumo, F. 1994. Endothelin ETA receptor antagonist blocks cardiac hypertrophy provoked by hemody-namic overload. Circulation 89:2198-2203.
Izumo, S., Nadal-Ginard, B., and Mahdavi, V. 1988. Proto-oncogene induction and reprogram-ming of the cardiac gene expression produced by pressure-overload. Proc. Natl. Acad. Sci. USA 85:339-343.
Jin, H., Yang, R., Li, W., Ryan, A., Ogasawara, A.K., Peborgh, J.V., and Paoni, N.F. 2000. Effects of exercise training on cardiac function gene expression, and apoptosis in rats. Am. J. Physiol. 279:H2994-H3002.
Katz, A.M. 1990. Cardiomyopathy of overload: A major determinant of prognosis in congestive heart failure. N. Engl. J. Med. 322:100-110.
Kee, H.J., Sohn, I.S., Nam, K.I., Park, J.E., Qian, Y.R., Yin, Z., Ahn, Y., Jeong, M.H., Bang, Y.J., Kim, N., Kim, J.K., Epstein, J.A., and Kook, H. 2006. Inhibition of histone deacetylation blocks cardiac hypertrophy induced by angiotensin II and aortic banding. Circulation 113:51-59.
Kinugawa, S., Tsutsui, H., Ide, T., Nakamura, R., Arimura, K., Egashira, K., and Takeshita, A. 1999. Positive inotropic effect of insulin-like growth factor-1 on normal and failing cardiac myocytes. Cardiovasc. Res. 43:157-164.
Konhilas, J.P., Maass, A.H., Luckey, S.W., Stauffer, B.L., Olson, E.N., and Leinwand, L.A. 2004. Sex modifies exercise and cardiac adaptation in mice. Am. J. Physiol. 287:H2768-H2776.
Li, Q., Li, B., Wang, X., Leri, A., Jana, K., Lui, Y., Kajstura, J., Baserga, R., and Anversa, P. 1997. Overexpression of insulin-like growth factor-1 in mice protects from death after infarction, at-tenuating ventricular dilatation, wall stress, and cardiac hypertrophy. J. Clin. Invest. 100:1991-1999.
Lijnen, P., and Petrov, V. 1999. Renin-angiotensin system, hypertrophy and gene expression in cardiac myocytes. J. Mol. Cell. Cardiol. 31:949-970.
Lim, H.W., De Windt, L.J., Steiberg, L., Taigen, T., Witt, S.A., Kimball, T.R., and Molkentin, J.D. 2000. Calcineurin expression, activation, and function in cardiac pressure-overload hypertrophy. Circulation 101:2431-2437.
Luo, J., McMullen, J.R., Sobkiw, C.L., Zhang, L., Dorfman, A.L., Sherwood, M.C., Logsdon, M.N., Horner, J.W., DePinho, R.A., Izumo, S., and Cantley, L.C. 2005. Class 1A phosphoinositide 3-kinase regulates heart size and physiological cardiac hypertrophy. Mol. Cell. Biol. 25:9491-9502.
Malhotra, R., Sadoshima, J., Brosius, F.C. 3rd , and Izumo, S. 1999. Mechanical stretch and an-giotensin II differentially upregulate the renin-angiotensin system in cardiac myocytes in vitro. Circ. Res 85:137-146.
Marino, T.A., Kent, R.L., Uboh, C.E., Fernandez, E., Thompson, E.W., and Cooper, G., 1985. Structural analysis of pressure versus volume overload hypertrophy of cat right ventricle. Am. J. Physiol. 249:H371-H379.
Masashi, A., Matsui, H., and Periasamy, M. 1994. Sarcoplasmic reticulum gene expression in cardiac hypertrophy and heart failure. Circ. Res. 64:555-564.
Matthews, K.G., Devlin, G.P., Conaglen, J.V., Stuart, S.P., Mervyn Aitken, W., and Bass, J.J. 1999. Changes in IGFs in cardiac tissue following myocardial infarction. J. Endocrinol. 163:433-445.
Mazzolai, L., Nussberger, J., Aubert, J.F., Brunner, D.B., Gabbiani, G., Bruner, H.R., and Pedrazzini, T. 1998. Blood pressure-independent cardiac hypertrophy induced by locally activated renin-angiotensin system. Hypertension 31:1324-1330.
McMullen, J., Shioi, T., Zhang, L., Tarnavaski, O., Sherwood, M.C., Kang, P.M., and Izumo, S. 2003. Phosphoinositide 3-kinase (p110α) plays a critical role for the induction of physiological, but not pathological cardiac hypertrophy. Proc. Natl. Acad. Sci. USA 100:12355-12360.
McMullen, J., Shioi, T., Huang, W.-Y., Zhang, L., Tarnavaski, O., Bisping, E., Schinke, M., Kong, S., Sherwood, M.C., Brown, J., Riggi, L., Kang, P.M., and Izumo, S. 2004. The insulin-like growth factor 1 receptor induces physiological heart growth via the phosphoinositide 3-kinase (p110α) pathway. J. Biol. Chem. 279:4782-4793.
Mercadier, J.J., Lompre, A.M., Wisnewsky, C., Samuel, J.L., Bercovici, J., Swynghedauw, B., and Schwartz, K. 1981. Myosin isoenzymatic changes in several models of cardiac hypertrophy. Circ. Res. 49:525-532.
Modesti, P.A., Vanni, S., Bertolozzi, I., Cecioni, I., Polidori, G., Paniccia, R., Bandinelli, B., Perna, A., Liguori, P., Boddi, M., Galanti, G., and Serneri, G.G.N. 2000. Early sequence of cardiac adaptations and growth factor formation in pressure- and volume-overload hypertrophy. Am. J. Physiol. 279:H976-H985.
Mohabir, R., Young, S.D., and Strosberg, A.M. 1994. Role of angiotensin in pressure overload-induced hypertrophy in rats: effects of angiotensin-converting enzyme inhibitors, an AT1 recep-tor antagonist, and surgical reversal. J. Cardiovasc. Pharmacol. 23:291-299.
Molkentin, J.D., Lu, J.-R., Antos, C.L., Robbins, J., Grant, S.R., and Olson, E.N. 1998. A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell 93:215-228.
Moore, R.L., Musch, T.I., Yelamarty, R.V., Scaduto, R.C., Jr., Semanchick, A.M., Elensky, M., and Cheung, J.Y. 1993. Chronic exercise alters contractility and morphology of isolated cardiac myocytes. Am. J. Physiol. 264: C1180-C1189.
Morkin, E. 1970. Postnatal muscle fiber assembly: localization of newly synthesized myofibrillar proteins. Science 167:1499-1501.
Nadal-Ginard, B., and Mahdavi, V. 1989. Molecular basis of cardiac performance: plasticity of the myocardium generated through protein isoform switches. J. Clin. Invest. 84:1693-1700.
Naga Prasad, S.V., Esposito, G., Mao, L., Koch, W.J., and Rockman, H.A. 2000. Gβγ-dependent phosphoinositide 3-kinase activation in hearts with in vivo pressure overload hypertrophy. J. Biol. Chem. 275:4693-4698.
Obata, K., Nagata, K., Iwase, M., Odashima, M., Nagasaka, T., Izawa, H., Murohara, T., Yamada, Y., and Yokota, M. 2005. Overexpression of calmodulin induces cardiac hypertrophy by a calcineurin-dependent pathway. Biochem. Biophys. Res. Commun. 338:1299-1305.
Paradis, P., Dali-Youcef, N., Paradis, F.W., Thibault, G., and Nemer, M. 2000. Overexpression of angiotensin II type 1 receptor in cardiomyocytes induced cardiac hypertrophy and remodelling. Proc. Natl. Acad. Sci. USA 97:931-936.
Parker, T.G., Packer, S.E., and Schneider, M.D. 1990. Peptide growth factors can provoke fetal contractile gene expression in rat cardiac myocytes. J. Clin. Invest. 85:507-514.
Redaelli, G., Malhotra, A., Li, B., Li, P., Sonneblick, E.H., Hofmann, P.A., and Anversa, P. 1998. Effects of constitutive overexpression of insulin-like growth factor-1 on the mechanical charac-teristics and molecular properties of ventricular myocytes. Circ. Res. 82:594-603.
Rockman, H.A., Wachhorst, S.P., Mao, L., and Ross, J., Jr. 1994. ANG II receptor blockade pre-vents ventricular hypertrophy and ANF gene expression with pressure overload in mice. Am. J. Physiol. 266:H2468-H2475.
Rothermel, B.A., Vega, R.B., Yang, J., Wu, H., Bassel-Duby, R., and Williams, R.S. 2000. A pro-tein encoded within the down syndrome critical region is enriched in striated muscles and in-hibits calcineurin signalling. J. Biol. Chem. 275:8719-8725.
Rothermel, B.A., McKinsey, T.A., Vega, R.B., Nicol, R.L., Mammen, P., Yang, J., Antos, C.L., Shelton, J.M., Bassel-Duby, R., Olson, E.N., and Williams, R.S. 2001. Myocyte-enriched calcineurin-interacting protein, MCIP1, inhibits cardiac hypertrophy in vivo. Proc. Natl. Acad. Sci. USA 98:3328-3333.
Ruzicka, M., Yuan, B., and Leenen, F.H. 1994. Effects of enalapril versus losartan on regression of volume overload-induced cardiac hypertrophy in rats. Circulation 90:484-491.
Ruzicka, M., Skarda, V., and Leenen, F.H.H. 1995. Effects of ACE inhibitors on circulating ver-sus cardiac angiotensin II in volume overload induced cardiac hypertrophy in rats. Circulation 92:3568-3573.
Sadoshima, J., and Izumo, S. 1993. Molecular characterization of angiotensin II-induced hypertro-phy of cardiac myocytes and hyperplasia of cardiac fibroblasts. Critical role of the AT1 receptor subtype. Circ. Res. 73:413-423.
Scheinowitz, M., Kessler-Icekson, G., Freimann, S., Zimmerman, R., Schaper, W., Golomb, E., Savion, N., and Eldar, M. 2003. Short- and long-term swimming exercise training increases myocardial insulin-like growth factor-1 gene expression. Growth Hormone IGF Res. 13:19-25.
Schiaffino, S., Samuel, J.L., Sassoon, D., Lompre, A.M., Garner, I., Marotte, F., Buckingham, M., Rappaport, L., and Schwartz, K. 1989. Nonsynchronous accumulation of α-skeletal actin and β-myosin heavy chain mRNA’s during the early stages of pressure-overload induced cardiac hypertrophy demonstrated by in situ hybridization. Circ. Res. 64:937-948.
Schultz, J.E.J., Witt, S.A., Glascocj, B.J., Neiman, M.L., Reiser, P.J., Nix, S.L., Kimball, T.R., and Doetschman, T. 2002. TGF-β1 mediates the hypertrophic cardiomyocyte growth induced by angiotensin II. J. Clin. Invest. 109:787-796.
Serneri, G.G.N., Boddi, M., Modesti, P.A., Cecioni, I., Coppo, M., Padeletti, L., Michelucci, A., Colella, A., and Galanti, G. 2001. Increased sympathetic activity and insulin-like growth factor-1 formation are associated with physiological hypertrophy in athletes. Circ. Res. 89:977-982.
Serneri, G.G.N., Modesti, P.A., Boddi, M., Cecioni, I., Paniccia, R., Coppo, M., Simonetti, I., Vanni, S., Papa, L., Bandinelli, B., Migliorini, A., Modesti, A., Maccherini, M., Sani, G., and Toscano, M. 1999. Cardiac growth factors in human hypertrophy: relations with myocardial contractility and wall stress. Circ. Res. 85:57-67.
Shioi, T., Kang, P., Douglas, P.S., Hampe, J., Yballe, C.M., Lawitts, J., Cantley, L.C., and Izumo, S. 2000. The conserved phosphoinositide 3-kinase pathway determines heart size in mice. Cell 19:2537-2548.
Shubieta, H.E., McDonough, P.M., Harris, A.N., Knowlton, K.U., Glembotski, C.C., Brown, J.H., and Chien, K.R. 1990. Endothelin induction of inositol phosphate hydrolysis, sarcomere assem-bly, and cardiac gene expression in ventricular myocytes. A paracrine mechanism for myocar-dial cell hypertrophy. J.Biol. Chem. 265:20555-20562.
Strait, J.B., Martin, J.L., Bayer, A., Mestril, R., Eble, D.M., and Samarel, A.M. 2001. Role of protein kinase C-ε in hypertrophy of cultured neonatal rat ventricular myocytes. Am. J. Physiol. 280:H756-H766.
Takeishi, Y., Ping, P., Bolli, R., Kirkpatrick, D.L., Hoit, B.D., and Walsh, R.A. 2000. Transgenic overexpression of constitutively active protein kinase C εcauses concentric cardiac hypertrophy. Circ. Res. 86:1218-1223.
Thompson, N.L., Bazoberry, F., Speir, E.H., Casscells, W., Ferrans, V.J., Flamnder, K.C., Kondaiah, P., Geiser, A.G., and Sporn, M.B. 1988. Transforming growth factor beta-1 in acute myocardial infarction in rats. Growth Factors 1:91-99.
Vijayan, K., Szotek, E.L., Martin, J.L., and Samarel, A.M. 2004. Protein kinase C-α-induced hy-pertrophy of neonatal rat ventricular myocytes. Am. J. Physiol. 287:H2777-H2789.
von Lewinski, D., Voss, K., Hulsmann, S., Kogler, H., and Pieske, B. 2003. Insulin-like growth factor-1 exerts Ca2+ -dependent positive inotropic effects in failing human myocardium. Circ. Res. 92:169-176.
Weinberg, E.O., Lee, M.A., Weigner, M., Lindpianter, K., Bishop, S.P., Benedict, C.R., Douglas, P.S., Chafizadeh, E., and Lorell, B.H. 1997. Angiotensin AT1 receptor inhibition. Effects on hypertrophic remodelling and ACE expression in rats with pressure-overload hypertrophy due to ascending aortic stensois. Circulation 95:1592-1600.
Zak, R. 1974. Development and proliferative capacity of cardiac muscle cells. Circ. Res. 34-35 (Suppl. II):17-25.
Zhang, T., Johnson, E.N., Gu, Y., Morissette, M.R., Sah, V.P., Gigena, M.S., Belke, D.D., Dillman, W.H., Rogers, T.B., Schulman, H., Ross, J., Jr., and Brown, J.H. 2002. The cardiac-specific nuclear δB isoform of Ca2+ /calmodulin dependent protein kinase II induces hypertrophy and dilated cardiomyopathy associated with increased protein phosphatase 2A activity. J. Biol. Chem. 277:1261-1267.
Zhang, T., Maier, L.S., Dalton, N.D., Miyamoto, S., Ross, J., Jr., Bers, D.M., and Brown, J.H. 2003. The δc isoform of CaMKII is activated in cardiac hypertrophy and induces dilated car-diomyopathy and heart failure. Circ. Res. 92:912-919.
Zhu, W., Zou, Y., Shiojima, I., Kudoh, S., Aikawa, R., Hayashi, D., Mizukami, M., Toko, H., Shibasaki, F., Yazaki, Y., Nagai, R., and Komuro, I. 2000. Ca2+ /calmodulin-dependent kinase II and calcineurin play critical roles in endothelin-1-induced cardiomyocyte hypertrophy. J. Biol. Chem. 275:15239-15245.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Calderone, A. (2008). Identifying the Cellular and Molecular Events Associated with the Divergent Phenotypes of Cardiac Hypertrophy. In: Srivastava, A.K., Anand-Srivastava, M.B. (eds) Signal Transduction in the Cardiovascular System in Health and Disease. Advances in Biochemistry in Health and Disease, vol 3. Springer, Boston, MA. https://doi.org/10.1007/978-0-387-09552-3_12
Download citation
DOI: https://doi.org/10.1007/978-0-387-09552-3_12
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-387-09551-6
Online ISBN: 978-0-387-09552-3
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)